<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>3(4)</volume><submitter>Zhang BJ</submitter><pubmed_abstract>Epigenetic regulation refers to alterations to the chromatin template that collectively establish differential patterns of gene transcription. Post-translational modifications of the histones play a key role in epigenetic regulation of gene transcription. In this review, we provide an overview of recent studies on the role of histone modifications in carcinogenesis. Since tumour-selective ligands such as tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) are well-considered as promising anti-tumour therapies, we summarise strategies for improving TRAIL sensitivity by inhibiting aberrant histone modifications in cancers. In this perspective we also discuss new epigenetic drug targets for enhancing TRAIL-mediated apoptosis.</pubmed_abstract><journal>Cancer drug resistance (Alhambra, Calif.)</journal><pagination>791-803</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8992553</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Improving TRAIL-induced apoptosis in cancers by interfering with histone modifications.</pubmed_title><pmcid>PMC8992553</pmcid><pubmed_authors>Quax WJ</pubmed_authors><pubmed_authors>Zhang BJ</pubmed_authors><pubmed_authors>Chen D</pubmed_authors><pubmed_authors>Dekker FJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Improving TRAIL-induced apoptosis in cancers by interfering with histone modifications.</name><description>Epigenetic regulation refers to alterations to the chromatin template that collectively establish differential patterns of gene transcription. Post-translational modifications of the histones play a key role in epigenetic regulation of gene transcription. In this review, we provide an overview of recent studies on the role of histone modifications in carcinogenesis. Since tumour-selective ligands such as tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) are well-considered as promising anti-tumour therapies, we summarise strategies for improving TRAIL sensitivity by inhibiting aberrant histone modifications in cancers. In this perspective we also discuss new epigenetic drug targets for enhancing TRAIL-mediated apoptosis.</description><dates><release>2020-01-01T00:00:00Z</release><publication>2020</publication><modification>2025-05-18T12:04:48.949Z</modification><creation>2025-04-05T20:38:38.415Z</creation></dates><accession>S-EPMC8992553</accession><cross_references><pubmed>35582230</pubmed><doi>10.20517/cdr.2020.58</doi></cross_references></HashMap>